Tailored Therapy Guided by Antibiotic Genotypic Resistances and CYP2C19 Polymorphisms Detected From Fecal Specimens for the First‐Line Helicobacter pylori Eradication: A Randomized Controlled Trial

医学 基因型 粪便 随机对照试验 内科学 胃肠病学 临床试验 抗生素治疗 抗生素 多态性(计算机科学)
作者
Baojun Suo,Xinlu Ren,Cailing Li,Yanyan Shi,Xueli Tian,Kai Zhou,Liya Zhou,Zhiqiang Song
出处
期刊:Helicobacter [Wiley]
卷期号:30 (5): e70082-e70082 被引量:5
标识
DOI:10.1111/hel.70082
摘要

ABSTRACT Background Tailored therapy based on genetic testing of fecal samples is a promising method for Helicobacter pylori eradication, but relevant research is still lacking, and the effectiveness remains unclear. Objective This study conducted a randomized controlled trial to evaluate the efficacy, safety, and compliance of triple plus bismuth therapy (TBT) guided by clarithromycin and levofloxacin genotypic resistances and CYP2C19 polymorphisms from stool samples. A preliminary health economics analysis was also conducted. Design Six hundred and sixteen treatment‐naïve patients were randomly divided into tailored (individualized drug selection based on genetic testing for 7 or 14 days) and empiric (esomeprazole 20 mg, amoxicillin 1000 mg, clarithromycin 500 mg, and bismuth potassium citrate 220 mg, all twice daily for 14 days) TBT groups. Safety and compliance were assessed within 1–3 days after eradication. 13 C‐urea breath test was performed within 4–8 weeks after eradication to evaluate the therapeutic outcome. Results The eradication rates of the tailored TBT group were non‐inferior to those of the empiric TBT group [intention‐to‐treat analysis 87.7% vs. 80.8%, rate difference 6.8% (95% confidence interval 0.8%–12.9%); modified intention‐to‐treat analysis 93.4% vs. 86.8%, rate difference 6.7% (95% confidence interval 1.5%–11.9%); per‐protocol analysis 95.7% vs. 88.7%, rate difference 7.0% (95% confidence interval 2.2%–11.8%)]. The tailored TBT group achieved satisfactory efficacies (acceptable in intention‐to‐treat and excellent in per‐protocol analyses). Safety and compliance were similar between the two groups. The average cost of each successful eradication case in the tailored TBT group is lower than that in the empiric TBT group. Conclusion The tailored TBT guided by antibiotic genotypic resistances and CYP2C19 polymorphisms detected from fecal specimens achieved satisfactory efficacy, safety, and compliance in the first‐line Helicobacter pylori eradication with less expenses (ChiCTR2300068620). Trial Registration Chinese Clinical Trials Registration: ChiCTR2300068620
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
yuuu完成签到 ,获得积分10
1秒前
1秒前
永无完成签到,获得积分10
1秒前
cdercder的应助被L_采纳,获得10
1秒前
1秒前
马也发布了新的文献求助10
2秒前
2秒前
2秒前
Peiqi的应助被Maestro_S采纳,获得30
2秒前
3秒前
AXX041795发布了新的文献求助20
3秒前
3秒前
他说发布了新的文献求助10
3秒前
ll完成签到 ,获得积分10
4秒前
西瓜炒蛋完成签到,获得积分10
4秒前
5秒前
文文完成签到,获得积分10
5秒前
正在消融的冰完成签到,获得积分10
5秒前
wxs完成签到,获得积分10
6秒前
紧张的向雁完成签到,获得积分10
6秒前
闾丘翠桃发布了新的文献求助10
6秒前
鲤鱼晟睿完成签到,获得积分20
6秒前
kaikaifilu完成签到 ,获得积分10
7秒前
叶落风行发布了新的文献求助30
7秒前
卡卡完成签到,获得积分10
7秒前
MCFCSH发布了新的文献求助10
7秒前
可爱的函函的应助被yuuu采纳,获得10
8秒前
whhhhhh发布了新的文献求助20
8秒前
Pepsi完成签到,获得积分10
8秒前
8秒前
章鱼哥完成签到,获得积分10
9秒前
ljj完成签到,获得积分10
9秒前
9秒前
王的故郷完成签到,获得积分10
9秒前
mimi完成签到,获得积分10
10秒前
10秒前
无字诉题发布了新的文献求助10
10秒前
酷波er的应助被ZM采纳,获得10
10秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105